• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[家族性腺瘤性息肉病:临床医生需要了解的新进展?]

[Familial adenomatous polyposis: what is new for the clinician?].

作者信息

Coppens J P, Kartheuser A, Verellen-Dumoulin C, Gribomont A C, Detry R, Van Heuverzwyn R

机构信息

Centre de Colo-Proctologie, Cliniques Universitaires Saint-Luc, Bruxelles.

出版信息

Acta Gastroenterol Belg. 1992 Sep-Dec;55(5-6):457-61.

PMID:1337641
Abstract

Familial adenomatous polyposis (FAP) is a rare autosomal-dominant disease characterized by the development of more than 100 colorectal adenomatous polyps in young adults. In the absence of surgical intervention, colorectal cancer ineluctably develops in all affected patients. Recent progress in the isolation of the gene responsible for the disease allows to detect gene carriers before they present with symptoms attributable to polyps. Moreover, the presence of four or more lesions of congenital hypertrophy of the retinal pigment epithelium is an extracolonic manifestation of FAP allowing presymptomatic screening of this disease. An effective screening programme combined with the elaboration of a registry for FAP and prophylactic colectomy should reduce mortality related to colorectal cancer. Two other extracolonic manifestations of FAP remain major causes of death: abdominal desmoid tumors and duodenal adenocarcinoma. At this time, no effective medical or surgical therapy has been found to cure these lesions. Restorative proctocolectomy with ileal reservoir is another major advance. This procedure is now regarded as the treatment of choice for patients with FAP because radical removal of all premalignant colorectal mucosa eliminates the risk of subsequent development of a colorectal adenocarcinoma.

摘要

家族性腺瘤性息肉病(FAP)是一种罕见的常染色体显性疾病,其特征是在年轻人中出现100多个结直肠腺瘤性息肉。若不进行手术干预,所有患病患者都会不可避免地发展为结直肠癌。在分离导致该疾病的基因方面取得的最新进展,使得能够在基因携带者出现息肉相关症状之前检测到他们。此外,视网膜色素上皮先天性肥大出现四个或更多病变是FAP的一种肠外表现,可用于该疾病的症状前筛查。一个有效的筛查计划,结合建立FAP登记册和预防性结肠切除术,应能降低与结直肠癌相关的死亡率。FAP另外两种肠外表现仍然是主要死因:腹部硬纤维瘤和十二指肠腺癌。目前,尚未发现有效的药物或手术治疗方法来治愈这些病变。回肠储袋肛管吻合术是另一项重大进展。该手术现在被视为FAP患者的首选治疗方法,因为彻底切除所有癌前结直肠黏膜可消除随后发生结直肠癌的风险。

相似文献

1
[Familial adenomatous polyposis: what is new for the clinician?].[家族性腺瘤性息肉病:临床医生需要了解的新进展?]
Acta Gastroenterol Belg. 1992 Sep-Dec;55(5-6):457-61.
2
Familial adenomatous polyposis.家族性腺瘤性息肉病。
Orphanet J Rare Dis. 2009 Oct 12;4:22. doi: 10.1186/1750-1172-4-22.
3
[Proctocolectomy with ileoanal anastomoses and desmoid tumor treated with resection. One case of familial adenomatous polyposis].[回肠肛管吻合术和硬纤维瘤切除术治疗的直肠结肠切除术。家族性腺瘤性息肉病1例]
Rev Med Inst Mex Seguro Soc. 2014 Sep-Oct;52(5):594-7.
4
Familial polyposis coli: clinical manifestations, evaluation, management and treatment.家族性腺瘤性息肉病:临床表现、评估、管理与治疗
Mt Sinai J Med. 2004 Nov;71(6):384-91.
5
[Familial adenomatous polyposis. Problems encountered with rectum preservation in surgical treatment and life expectancy].[家族性腺瘤性息肉病。手术治疗中保留直肠所遇到的问题及预期寿命]
Ann Ital Chir. 1995 Sep-Oct;66(5):671-83.
6
Familial adenomatous polyposis: a case report and review of the literature.家族性腺瘤性息肉病:一例病例报告及文献综述
J Natl Med Assoc. 2001 Jun;93(6):208-13.
7
Outcome of familial adenomatous polyposis: a retrospective study.家族性腺瘤性息肉病的结局:一项回顾性研究。
J Med Assoc Thai. 2006 Sep;89 Suppl 3:S155-60.
8
Colorectal family polyadenomatous diseases. What management in 2020?结直肠腺瘤性家族性疾病。2020 年的管理方法是什么?
J Visc Surg. 2020 Apr;157(2):127-135. doi: 10.1016/j.jviscsurg.2019.12.003. Epub 2020 Feb 26.
9
[Preventive surgery for familial adenomatous polyposis coli].[家族性腺瘤性息肉病的预防性手术]
Chirurg. 2005 Dec;76(12):1125-34. doi: 10.1007/s00104-005-1115-x.
10
[Familial adenomatous polyposis (FAP): integration of clinical and genetic parameters in the screening of subjects at risk. A one-family example].
Swiss Surg. 1996;2(5):196-200.